Eligibility Requirements
Covered Medications
The following medications are covered by myAbbVie Assist:
What Makes myAbbVie Assist Different
myAbbVie Assist is one of the largest patient assistance programs in the pharmaceutical industry, serving over 100,000 patients annually across dozens of AbbVie medications. The program's 600% FPL income threshold is the highest among major manufacturer PAPs, meaning a single individual earning up to approximately $90,360 per year may still qualify. For comparison, most competing programs cap eligibility at 300% to 400% FPL. This generous threshold reflects AbbVie's portfolio of high-cost specialty drugs, where even middle-income patients face significant financial barriers.
The financial impact of myAbbVie Assist is substantial when measured against retail pricing. Humira carries a list price above $6,000 per month, though the arrival of biosimilar competitors (Hadlima, Hyrimoz, Cyltezo, and others) has begun shifting the market. Oncology drugs covered by the program represent even larger savings: Venclexta (venetoclax) for chronic lymphocytic leukemia runs
A few practical details are worth noting before you apply. Enrollment requires annual renewal, so mark your calendar roughly 30 days before your approval expires to avoid gaps in medication supply. AbbVie ships medications in 90-day quantities, which reduces the number of refill cycles but means you need adequate storage (Humira and Skyrizi require refrigeration). Patients already receiving medication through the program should be aware that switching to a biosimilar Humira product would require a separate assistance application through that biosimilar's manufacturer. If your income changes mid-year and you fall outside the 600% FPL threshold, notify the program promptly to avoid complications at renewal.
How to Apply
- Speak with your healthcare provider about myAbbVie Assist. Your doctor, nurse, or social worker can help determine if you qualify.
- Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
- Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
- Wait for approval (typically 2 to 6 weeks). Once approved, medications will be shipped to your provider's office or a designated pharmacy.
Check If You Qualify
Use our free Assistance Finder tool to check eligibility for myAbbVie Assist and other programs that may help reduce your medication costs.
Open Assistance FinderFrequently Asked Questions
Yes, both Humira (adalimumab) and Skyrizi (risankizumab) are covered by myAbbVie Assist. Eligible patients can receive these medications at no cost through the program.
myAbbVie Assist has one of the highest income thresholds among manufacturer PAPs, at up to 600% of the Federal Poverty Level for many medications. For a single individual in 2026, this is approximately $90,360 per year.
Your healthcare provider can enroll you by completing an application at abbvie.com/patients or by calling 1-800-222-6885. You will need to provide proof of income and a valid prescription.
Related Resources
- Compare pharmacy prices for Humira on RxGrab
- Humira supplement guide on Health Britannica
- Check drug interactions for Humira on OmniRx
- Browse all patient assistance programs
Get Prescription Savings Alerts
Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.